Domov › Nemalicelični pljučni rak › Texas › Irving
Klinične študije za Nemalicelični pljučni rak v Irving, TX
22 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Irving in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Vključevanje udeležencevFaza 1
- Exelixis Clinical Site #73, Irving
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Vključevanje udeležencevFaza 1
- NEXT Dallas, Irving
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 3
- US Oncology Investigational Product Center (IPC), Irving
- US Oncology Investigational Products Center (IPC), Irving
- US Oncology Investigational Products Center(IPC), Irving
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- US Oncology Investigational Products Center (IPC), Irving
- US Oncology Investigational Products Center, Irving
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Vključevanje udeležencevFaza 3
- US Oncology Research Investigational Products Center, Irving
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Vključevanje udeležencevFaza 1/2
- US Oncology Investigational Products Center (IPC), Irving
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology - Irving, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Dallas, Irving
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Vključevanje udeležencevFaza 1/2
- Next Oncology - Dallas, Irving
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Vključevanje udeležencevFaza 2/3
- Local Institution - 007-999, Irving
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Vključevanje udeležencevFaza 1/2
- Next Oncology Dallas, Irving
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Dallas - Oncology Department, Irving
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Dallas, Irving
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Dallas, Irving
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- US Oncology Investigational Product Center (IPC), Irving
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Vključevanje udeležencevFaza 1/2
- NEXT Oncology Dallas, Irving
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Vključevanje udeležencevFaza 1
- Next Oncology Dallas /ID# 276254, Irving
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Vključevanje udeležencevFaza 1
- NEXT Texas LLC - Dallas, Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology Dallas, Irving
A 2-part Phase 1/2 Open-label Trial on ODM-212
Vključevanje udeležencevFaza 1/2
- NEXT Oncology, Irving
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT, Dallas, Irving
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Vključevanje udeležencevFaza 1/2
- NEXT Dallas, Irving
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY120 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH56 študij
- Washington, DC55 študij
Druge študije v Irving
- Rak (vse vrste)15 študij
- Kolorektalni rak13 študij
- Metastatski rak11 študij
- Rak trebušne slinavke7 študij
- Rak želodca7 študij
- Ploščatocelični karcinom glave in vratu6 študij
- Rak dojke6 študij
- Mikrocitni rak pljuč6 študij
- Rak pljuč6 študij
- Rak jajčnikov5 študij
- Rak endometrija4 študij
- Rak prostate4 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.